These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34). Wang L, Quarles LD, Spurney RF. J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561 [Abstract] [Full Text] [Related]
5. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity. Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW. Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311 [Abstract] [Full Text] [Related]
6. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, Wigner NA, Toben D, Jacobsen KA, Al-Sebaei MO, Song M, Trackman PC, Morgan EF, Gerstenfeld LC, Barnes GL. J Bone Miner Res; 2007 Dec; 22(12):1903-12. PubMed ID: 17680724 [Abstract] [Full Text] [Related]
9. Effects of parathyroid hormone on Wnt signaling pathway in bone. Kulkarni NH, Halladay DL, Miles RR, Gilbert LM, Frolik CA, Galvin RJ, Martin TJ, Gillespie MT, Onyia JE. J Cell Biochem; 2005 Aug 15; 95(6):1178-90. PubMed ID: 15962290 [Abstract] [Full Text] [Related]
10. SOST is a target gene for PTH in bone. Keller H, Kneissel M. Bone; 2005 Aug 15; 37(2):148-58. PubMed ID: 15946907 [Abstract] [Full Text] [Related]
11. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis. Fukata S, Hagino H, Okano T, Yamane I, Kameyama Y, Teshima R. Arthritis Rheum; 2004 Dec 15; 50(12):4060-9. PubMed ID: 15593226 [Abstract] [Full Text] [Related]
12. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. Alexander JM, Bab I, Fish S, Müller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt M. J Bone Miner Res; 2001 Sep 15; 16(9):1665-73. PubMed ID: 11547836 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP. J Bone Miner Res; 2002 Sep 15; 17(9):1570-8. PubMed ID: 12211426 [Abstract] [Full Text] [Related]
16. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Fox J, Miller MA, Newman MK, Recker RR, Turner CH, Smith SY. Bone; 2007 Sep 15; 41(3):321-30. PubMed ID: 17573250 [Abstract] [Full Text] [Related]
17. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. Pfeilschifter J, Laukhuf F, Müller-Beckmann B, Blum WF, Pfister T, Ziegler R. J Clin Invest; 1995 Aug 15; 96(2):767-74. PubMed ID: 7635970 [Abstract] [Full Text] [Related]
18. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R. J Bone Miner Res; 2002 May 15; 17(5):808-16. PubMed ID: 12009011 [Abstract] [Full Text] [Related]
20. Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats. Skripitz R, Andreassen TT, Aspenberg P. Acta Orthop Scand; 2000 Dec 15; 71(6):619-24. PubMed ID: 11145391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]